Journal of Neurology

, 254:668 | Cite as

Metabolic deactivation of low-grade glioma during chemotherapy

  • Ulrich RoelckeEmail author
  • Matthias Wyss
  • Esther Bärtschi
  • Silvia Hofer


Positron Emission Tomography Temozolomide Flair Sequence Amino Acid Positron Emission Tomography Cantonal Hospital 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Brada M, Viviers L, Abson C, Hines F, Britton J, Ashley S, Sardell S, Traish D, Gonsalves A, Wilkins P, Westbury C (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715-721CrossRefPubMedGoogle Scholar
  2. 2.
    Hanahan D, Bergers G, Bergsland E (2000) Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest 105:1045-047CrossRefPubMedGoogle Scholar
  3. 3.
    Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R (1999) Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 40:1367-373PubMedGoogle Scholar
  4. 4.
    Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, Criniere E, Marie Y, Mokhtari K, Carpentier AF, Laigle F, Simon JM, Cornu P, Broet P, Sanson M, Delattre JY (2004) Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22:3133-138CrossRefPubMedGoogle Scholar
  5. 5.
    Husstedt HW, Sickert M, Kostler H, Haubitz B, Becker H (2000) Diagnostic value of the fast-FLAIR sequence in MR imaging of intracranial tumors. Eur Radiol 10:745-52CrossRefPubMedGoogle Scholar
  6. 6.
    Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-280PubMedGoogle Scholar
  7. 7.
    Miyagawa T, Oku T, Uehara H, Desai R, Beattie B, Tjuvajev J, Blasberg R (1998) “Facilitated-amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab 18:500-09CrossRefPubMedGoogle Scholar
  8. 8.
    Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, Kurlemann G, Wassmann H, Coenen HH, Schober O (2005) O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging 32:422-2CrossRefPubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2007

Authors and Affiliations

  • Ulrich Roelcke
    • 1
    Email author
  • Matthias Wyss
    • 2
  • Esther Bärtschi
    • 3
  • Silvia Hofer
    • 4
  1. 1.Dept. of NeurologyCantonal HospitalAarauSwitzerland
  2. 2.Dept. of Nuclear MedicineUniversity HospitalZürichSwitzerland
  3. 3.Dept. of Oncology and HematologyCantonal HospitalAarauSwitzerland
  4. 4.Dept. of OncologyUniversity HospitalZürichSwitzerland

Personalised recommendations